Usefulness of the GenMark ePlex RPP assay for the detection of respiratory viruses in comparison with the FTD21 multiplex RT-PCR
Cartridge-based multiplex panels overlaying quite a few pathogens provide a bonus of minimal hands-on-time and quick time to consequence to business RT-PCR assays. On this research, we evaluated the efficiency of the ePlex respiratory pathogen panel (RPP) in comparison with the Quick Monitor Diagnostics Respiratory pathogens 21 multiplex RT-PCR assay (FTD21) utilizing 400 medical respiratory samples. Discrepant outcomes had been additional analysed by a reference nucleic acid amplification testing (NAT) and a composite reference method was used for ultimate interpretation. Discordant outcomes had been noticed in 56 targets equivalent to 54 samples. Sensitivities and specificities had been 85.5% and 99.9% for the ePlex RPP and 95.8% and 99.7% for the FTD21 system, respectively. Altogether, the ePlex RPP is a worthwhile device for the speedy detection of quite a lot of completely different respiratory viruses apart from the coronavirus household (low sensitivity starting from 50-80%) and samples with a low pathogen load (Ct values >33).
Human Type 2 Diabetes Leukopak |
|||
ABC-TC4311 | AcceGen | 1 pack | Ask for price |
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's s inability to compensate by producing more RI. |
Diabetes (Type 1) Exosome RNA |
|||
P241-DB1 | 101Bio | - | Ask for price |
Diabetes (Type 2) Exosome RNA |
|||
P241-DB2 | 101Bio | - | Ask for price |
Human Type I Diabetes Peripheral Blood Mononuclear Cells |
|||
ABC-TC4263 | AcceGen | 1 vial | Ask for price |
Description: Peripheral blood mononuclear cells are isolated from Type I Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type I PBMCs is available upon request. |
Human Type II Diabetes PB Plasma |
|||
ABC-TC4266 | AcceGen | 1 vial | Ask for price |
Description: Type II Diabetes peripheral blood plasma is obtained by centrifugation of the Type II Diabetes PB. This product has a diminished number of cells and platelets. Fresh Diabetic Type II PB plasma is available upon request. |
Human iPS Cell Line (Type 2 Diabetes) |
|||
CSC-00849L | Creative Bioarray | One Frozen vial | Ask for price |
Single Donor Human Type II Diabetes Urine |
|||
IRHUURESDIBTII250ML | Innovative research | each | EUR 1063 |
Description: Single Donor Human Type II Diabetes Urine |
Single Donor Human Type II Diabetes Urine |
|||
IRHUURESDIBTII50ML | Innovative research | each | EUR 439 |
Description: Single Donor Human Type II Diabetes Urine |
Human Muscle Myoblasts, Diabetes Type II |
|||
ABC-TC3957 | AcceGen | 1 vial | Ask for price |
Description: Diabetic Type I and Type II HSMM-Human Skeletal Muscle Myoblasts are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Scientific Support. |
HighQC™ Human IPS Cell (Type 2 Diabetes) |
|||
ABC-SC0005T | AcceGen | 1 vial | Ask for price |
Description: Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells . The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells. |
Human Type II Diabetes Peripheral Blood Mononuclear Cells |
|||
ABC-TC4265 | AcceGen | 1 vial | Ask for price |
Description: Human Peripheral Blood Mononuclear Cells are available as positive and negative controls for T-cell monitoring in ELISPOT, ELISA, cytokine bead array, tetramer/pentamer, and flow cytometry assays. A peripheral blood mononuclear cell is defined as any blood cell with a round nucleus. These blood cells are a critical component in the immune system to fight infection and adapt to intruders. The lymphocyte population consists of CD4+ and CD8+ T cells, B cells and Natural Killer cells, CD14+ Monocytes, and Basophils/Neutrophils/Eosinophils/Dendritic cells. These cells are often extracted from whole blood or from leukopacks using ficoll, a hydrophilic polysaccharide that separates layers of blood, with monocytes and lymphocytes forming a buffy coat under a layer of plasma.Samples from each donor are tested via PCR to confirm non-reactivity. Peripheral blood mononuclear cells are isolated from Type II Diabetes peripheral blood by diluting the whole blood with PBS and using gradient separation techniques. After centrifugation,the mononuclear cell layer is collected. Mononuclear Cells can be processed further to isolate subpopulations. Fresh Diabetic Type II PBMCs is available upon request. |
HighQC™ Human IPS Cell (Episomal/ Diabetes Type II/ Adipose) |
|||
ABC-SC0011T | AcceGen | 1 vial | Ask for price |
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions. |
HighQC™ Human IPS Cell (IPSC From PBMC/ Diabetes Type II/ Episomal) |
|||
ABC-SC0009T | AcceGen | 1 vial | Ask for price |
Description: Gentaur offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson's Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions. |
HighQC™ Human IPS Cell (IPSC From Fibroblast/ Diabetes Type II/ Episomal) |
|||
ABC-SC0010T | AcceGen | 1 vial | Ask for price |
Description: Gentaur is is proud to offer human iPS cell lines derived from the human dermal fibroblasts from patients with Type 2 Diabetes (T2D). The pertinent donor information is available upon request. These iPS cells are established from a single clone and expanded in feeder-free conditions. Normal human iPS cell lines are also available as separate products . We also provide custom iPSC generation and iPSC differentiation services to meet your needs. |
Linearity FD Special Diabetes |
|||
K889M-5 | Audit MicroControls | 5 x 2 mL | EUR 374 |
HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cell/ Type II Diabetes Patient |
|||
ABC-SC0027T | AcceGen | 1 vial | Ask for price |
Description: Human MSCs (Bone Marrow Derived) from a single adult donor clinically diagnosed with Type II Diabetes. The MSCs are compatible with our MSC Expansion Medium for Bone Marrow Derived MSCs.All of the cells provided are tested and are negative for HIV-1, HIV-2, Hepatitis B and Hepatitis C as detected by PCR. The cells are confirmed to be negative for mycoplasma and other detectable microbial contamination. |
Single Donor Human Diabetes Serum |
|||
ISERSDIB | Innovative research | each | EUR 209 |
Description: Single Donor Human Diabetes Serum |
Human Diabetes Lung Tissue Lysate |
|||
IHULGDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Lung Tissue Lysate |
Single Donor Human Diabetes Plasma |
|||
IPLASDIB | Innovative research | each | EUR 209 |
Description: Single Donor Human Diabetes Plasma |
Human Diabetes Ileum Tissue Lysate |
|||
IHUILMDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Ileum Tissue Lysate |
Human Diabetes Colon Tissue Lysate |
|||
IHUCLNDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Colon Tissue Lysate |
Human Diabetes Jejunum Tissue Lysate |
|||
IHUJEJDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Jejunum Tissue Lysate |
Human Diabetes Stomach Tissue Lysate |
|||
IHUSTDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Stomach Tissue Lysate |
Human Diabetes Duodenum Tissue Lysate |
|||
IHUDUODIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Duodenum Tissue Lysate |
Human Diabetes Pancreas Tissue Lysate |
|||
IHUPCSDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Pancreas Tissue Lysate |
Human Diabetes Esophagus Tissue Lysate |
|||
IHUESOPDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Esophagus Tissue Lysate |
Human Diabetes AdiposeVisceral Tissue Lysate |
|||
IHUADPTVDIBTL100UG | Innovative research | each | EUR 2663 |
Description: Human Diabetes AdiposeVisceral Tissue Lysate |
Human Diabetes Skeletal Muscle Tissue Lysate |
|||
IHUSKMDIBTL100UG | Innovative research | each | EUR 1413 |
Description: Human Diabetes Skeletal Muscle Tissue Lysate |
Diabetes Drug Leads Bioactive Peptide Library |
|||
L-012 | PHOENIX PEPTIDE | 160 peptides | EUR 7938 |
Human Diabetes AdiposeSubcutaneous Tissue Lysate |
|||
IHUADPTSDIBTL100UG | Innovative research | each | EUR 2663 |
Description: Human Diabetes AdiposeSubcutaneous Tissue Lysate |
Human Diabetes Pancreas Lysate Membrane Fraction |
|||
IHUPCSDIBTLM100UG | Innovative research | each | EUR 1199 |
Description: Human Diabetes Pancreas Lysate Membrane Fraction |
Linearity FLQ Special Diabetes for Roche Systems |
|||
K929M-5 | Audit MicroControls | 5 x 2 mL | EUR 374 |
Linearity FLQ Special Diabetes for Abbott Systems |
|||
K956M-5 | Audit MicroControls | 5 x 2 mL | EUR 374 |
Human Diabetes Skeletal Muscle Lysate Membrane Fraction |
|||
IHUSKMDIBTLM100UG | Innovative research | each | EUR 1199 |
Description: Human Diabetes Skeletal Muscle Lysate Membrane Fraction |
HighQC™ Induced Pluripotent Stem Cell, From Diabetes (mellitus) |
|||
ABC-SC0241 | AcceGen | 1 vial | Ask for price |
Description: Diabetes (mellitus), Primary cell type: Fibroblast, Unknown vector detectable; Cells are only guaranteed with purchase of Gentaur Media and Gentaur Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment. |
Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
MG204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (untagged) - Mouse Ras-related associated with diabetes (Rrad), (10ug) |
|||
MC203288 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (untagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
RN208148 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
MR204351 | Origene Technologies GmbH | 10 µg | Ask for price |
Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
RR208148 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
SC322965 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (untagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
SC117559 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Rrad (mGFP-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
MR204351L4 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
RG202927 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (GFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
RG225433 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad) |
|||
MR204351L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Rrad (mGFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
RR208148L4 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 2 |
|||
RC202927 | Origene Technologies GmbH | 10 µg | Ask for price |
RRAD (Myc-DDK-tagged)-Human Ras-related associated with diabetes (RRAD), transcript variant 1 |
|||
RC225433 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), (10 ug) |
|||
RR208148L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 2, mGFP tagged |
|||
RC202927L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, mGFP tagged |
|||
RC225433L2 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, mGFP tagged |
|||
RC225433L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Rrad (GFP-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
MR204351L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Rrad (GFP-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
RR208148L4V | Origene Technologies GmbH | 200 µl | Ask for price |
3`UTR clone of Ras-related associated with diabetes (RRAD) transcript variant 2 for miRNA target validation |
|||
SC205326 | Origene Technologies GmbH | 10 µg | Ask for price |
3`UTR clone of Ras-related associated with diabetes (RRAD) transcript variant 1 for miRNA target validation |
|||
SC205328 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 2, Myc-DDK-tagged |
|||
RC202927L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, Myc-DDK-tagged |
|||
RC225433L1 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Human Ras-related associated with diabetes (RRAD), transcript variant 1, Myc-DDK-tagged |
|||
RC225433L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Rrad (Myc-DDK-tagged) - Mouse Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
MR204351L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Rrad (Myc-DDK-tagged ORF) - Rat Ras-related associated with diabetes (Rrad), 200ul, >10^7 TU/mL |
|||
RR208148L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (mGFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2, 200ul, >10^7 TU/mL |
|||
RC202927L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (mGFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC225433L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (mGFP-tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC225433L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (Myc-DDK tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 2, 200ul, >10^7 TU/mL |
|||
RC202927L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (Myc-DDK tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC225433L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, RRAD (Myc-DDK tagged) - Human Ras-related associated with diabetes (RRAD), transcript variant 1, 200ul, >10^7 TU/mL |
|||
RC225433L3V | Origene Technologies GmbH | 200 µl | Ask for price |
GCK (untagged)-Human glucokinase (hexokinase 4, maturity onset diabetes of the young 2), transcript variant 1 (cDNA clone MGC:1742 IMAGE:3536582) |
|||
SC127236 | Origene Technologies GmbH | 10 µg | Ask for price |
HighQC™ Diabetic Type I And Type II Adipose Derived Stem Cell |
|||
ABC-SC2109 | AcceGen | 1 vial | Ask for price |
Description: Human Adipose Derived Stem Cells (ADSC) from normal (non-diabetic) donors are available as a separate product. These cells have demonstrated very similar phenotypic and functional characteristics to that of bone marrow-derived mesenchymal stem cells. Diabetic Human Adipose Derived Stem Cells (ADSC) have been reported to differentiate down many different lineages including chondrogenic, osteogenic, adipogenic and neural. Diabetic Human Adipose Derived Stem Cells (ADSC) have been cryopreserved at primary passage. |
Human Dermal Microvascular EndoCells Diabetic Type I |
|||
ABC-TC3401 | AcceGen | 1 vial | Ask for price |
Description: Diseased endothelial cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease. Diseased cells are grown in the same optimized media system as normal human dermal microvascular endothelial cells. |
Human Cardiac Microvascular Endothelial Cells Diabetic Type I |
|||
ABC-TC3269 | AcceGen | 1 vial | Ask for price |
Description: Diseased endothelial cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease. Diseased cells are grown in the same optimized media system as normal human cardiac microvascular endothelial cells. Diabetic HMVE |
Pooled Human Semen |
|||
IRHUSM100ML | Innovative research | each | EUR 3800 |
Description: Pooled Human Semen |
Pooled Human Semen |
|||
IRHUSM1ML | Innovative research | each | EUR 88 |
Description: Pooled Human Semen |
Pooled Human Semen |
|||
IRHUSM20ML | Innovative research | each | EUR 905 |
Description: Pooled Human Semen |
Pooled Human Semen |
|||
IRHUSM5ML | Innovative research | each | EUR 341 |
Description: Pooled Human Semen |
Semen Identifier Kit |
|||
ML200-5R | EWC Diagnostics | 1 unit | EUR 6.63 |
Description: Semen Identifier Kit |
Single Donor Human Semen |
|||
IRHUSMS100ML | Innovative research | each | EUR 4120 |
Description: Single Donor Human Semen |
Single Donor Human Semen |
|||
IRHUSMS1ML | Innovative research | each | EUR 100 |
Description: Single Donor Human Semen |
Single Donor Human Semen |
|||
IRHUSMS20ML | Innovative research | each | EUR 962 |
Description: Single Donor Human Semen |
Single Donor Human Semen |
|||
IRHUSMS5ML | Innovative research | each | EUR 360 |
Description: Single Donor Human Semen |
Pooled Human Semen Cryopreserved |
|||
IRHUSMCRYP0.5ML | Innovative research | each | EUR 1170 |
Description: Pooled Human Semen Cryopreserved |
Hemacytometer-Disposable(Semen Test) |
|||
DHC-S022 | INCYTO | 20pcs/box | EUR 68.9 |
Hemacytometer-Disposable(Semen Test) |
|||
DHC-S025 | INCYTO | 50pcs/box | EUR 132.5 |
Single Donor Human Semen Swab |
|||
IRHUSSMSWB5 | Innovative research | each | EUR 3188 |
Description: Single Donor Human Semen Swab |
Prostate Specific Antign (Human Semen) |
|||
P1444-50 | Biovision | each | EUR 261.6 |
Single Donor Vasectomized Human Semen |
|||
IRHUSSMVSC1 | Innovative research | each | EUR 457 |
Description: Single Donor Vasectomized Human Semen |
Single Donor Vasectomized Human Semen |
|||
IRHUSSMVSC5 | Innovative research | each | EUR 2175 |
Description: Single Donor Vasectomized Human Semen |
Prostatic Acid Phosphatase, Human Semen |
|||
P1445-1 | Biovision | each | EUR 627.6 |
PSA-ACT Complex, Human Semen & Serum |
|||
P1448-10 | Biovision | each | EUR 405.6 |
Innovative Grade US Origin Bovine Semen |
|||
IGBOSMF | Innovative research | each | EUR 203 |
Description: Innovative Grade US Origin Bovine Semen |
Innovative Grade US Origin Bovine Semen |
|||
IGBOSMZ | Innovative research | each | EUR 203 |
Description: Innovative Grade US Origin Bovine Semen |
Human Dermal Microvascular EndoCells Diabetic Type II |
|||
ABC-TC3402 | AcceGen | 1 vial | Ask for price |
Description: Diseased endothelial cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease. Diseased cells are grown in the same optimized media system as normal human dermal microvascular endothelial cells. |
Genorise® Semen DNA Extraction Kit 1000 |
|||
GR101016 | Genorise Scientific | 1000 | EUR 1045 |
Genorise® Semen DNA Extraction Kit 500 |
|||
GR101041 | Genorise Scientific | 500 | EUR 480 |
Genorise® Semen DNA Extraction Kit 200 |
|||
GR101042 | Genorise Scientific | 200 | EUR 258 |
Genorise® Semen DNA Extraction Kit 100 |
|||
GR101043 | Genorise Scientific | 100 | EUR 144 |
Genorise® Semen DNA Extraction Kit 50 |
|||
GR101044 | Genorise Scientific | 50 | EUR 87 |
Human Cardiac Microvascular Endothelial Cells Diabetic Type II |
|||
ABC-TC3270 | AcceGen | 1 vial | Ask for price |
Description: Diseased endothelial cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease. Diseased cells are grown in the same optimized media system as normal human cardiac microvascular endothelial cells. Diabetic HMVE |
Genorise® Semen Stain DNA Extraction Kit 1000 |
|||
GR101017 | Genorise Scientific | 1000 | EUR 1045 |
Genorise® Semen Stain DNA Extraction Kit 500 |
|||
GR101069 | Genorise Scientific | 500 | EUR 564 |
Genorise® Semen Stain DNA Extraction Kit 200 |
|||
GR101070 | Genorise Scientific | 200 | EUR 243 |
Genorise® Semen Stain DNA Extraction Kit 100 |
|||
GR101071 | Genorise Scientific | 100 | EUR 144 |
Genorise® Semen Stain DNA Extraction Kit 50 |
|||
GR101072 | Genorise Scientific | 50 | EUR 87 |
AI-91K LN2 Freezer for Bulk Semen Storage, no controller |
|||
TW-AI-91K | MiTeGen | 1 UNIT | EUR 66671 |
Description: AI-91K LN2 Freezer for Bulk Semen Storage, no controller |
Semenogelin I Protein |
|||
20-abx261182 | Abbexa |
|
|
Semenogelin I Protein |
|||
abx261182-10g | Abbexa | 10 µg | EUR 325 |
Semenogelin I Protein |
|||
abx261182-2g | Abbexa | 2 µg | EUR 225 |
Semenogelin I antibody |
|||
70R-1587 | Fitzgerald | 100 ug | EUR 407 |
Description: Rabbit polyclonal Semenogelin I antibody raised against the N terminal of SEMG1 |
Semenogelin I antibody |
|||
70R-1593 | Fitzgerald | 100 ug | EUR 407 |
Description: Rabbit polyclonal Semenogelin I antibody raised against the C terminal of SEMG1 |
Semenogelin I antibody |
|||
70R-5491 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal Semenogelin I antibody raised against the middle region of SEMG1 |
Semenogelin I (SEMG1) Antibody |
|||
20-abx322135 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
20-abx320262 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
20-abx129235 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
20-abx174508 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
abx237711-100ug | Abbexa | 100 ug | EUR 661.2 |
Semenogelin I (SEMG1) Antibody |
|||
20-abx115422 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
20-abx004204 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
abx028130-400ul | Abbexa | 400 ul | EUR 627.6 |
Semenogelin I (SEMG1) Antibody |
|||
abx028130-80l | Abbexa | 80 µl | EUR 343.2 |
Semenogelin I (SEMG1) Antibody |
|||
abx004204-100l | Abbexa | 100 µl | EUR 400 |
Semenogelin I (SEMG1) Antibody |
|||
abx004204-20l | Abbexa | 20 µl | EUR 175 |
Semenogelin I (SEMG1) Antibody |
|||
abx004204-50l | Abbexa | 50 µl | EUR 275 |
Semenogelin I (SEMG1) Antibody |
|||
abx115422-100l | Abbexa | 100 µl | EUR 612.5 |
Semenogelin I (SEMG1) Antibody |
|||
abx129235-100l | Abbexa | 100 µl | EUR 275 |
Semenogelin I (SEMG1) Antibody |
|||
abx129235-1ml | Abbexa | 1 ml | EUR 750 |
Semenogelin I (SEMG1) Antibody |
|||
abx129235-200l | Abbexa | 200 µl | EUR 337.5 |
Semenogelin I (SEMG1) Antibody |
|||
abx237711-100g | Abbexa | 100 µg | EUR 350 |
Semenogelin I (SEMG1) Antibody |
|||
abx028130-400l | Abbexa | 400 µl | EUR 518.75 |
Semenogelin I (SEMG1) Antibody |
|||
abx174508-100l | Abbexa | 100 µl | EUR 787.5 |
Semenogelin I (SEMG1) Antibody |
|||
abx174508-1ml | Abbexa | 1 ml | Ask for price |
Semenogelin I (SEMG1) Antibody |
|||
abx174508-200l | Abbexa | 200 µl | Ask for price |
Semenogelin I (SEMG1) Antibody |
|||
abx320262-100l | Abbexa | 100 µl | EUR 350 |
Semenogelin I (SEMG1) Antibody |
|||
abx320262-50l | Abbexa | 50 µl | EUR 237.5 |
Semenogelin I (SEMG1) Antibody |
|||
abx322135-100g | Abbexa | 100 µg | EUR 350 |
Semenogelin I (SEMG1) Antibody |
|||
abx322135-50g | Abbexa | 50 µg | EUR 237.5 |
Recombinant Semenogelin I (SEMG1) |
|||
RPU51622-100ug | Biomatik Corporation | 100ug | EUR 492.8 |
Recombinant Semenogelin I (SEMG1) |
|||
RPU51622-1mg | Biomatik Corporation | 1mg | EUR 2184 |
Recombinant Semenogelin I (SEMG1) |
|||
RPU51622-50ug | Biomatik Corporation | 50ug | EUR 396 |
Recombinant Semenogelin I (SEMG1) |
|||
RPH185Hu01 | Cloud-Clone | 10ug | EUR 160 |
Recombinant Semenogelin I (SEMG1) |
|||
4-RPH185Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Semenogelin I expressed in: E.coli |
Semenogelin I Blocking Peptide |
|||
33R-3239 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1593 |
Semenogelin I Blocking Peptide |
|||
33R-4289 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-5491 |
Semenogelin I Blocking Peptide |
|||
33R-7601 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1587 |
Semenogelin I Human Recombinant |
|||
rAP-4051 | Angio Proteomie | Inquiry | Ask for price |
Human Semenogelin I ELISA Kit |
|||
IHUSEMG1KT | Innovative research | each | EUR 733 |
Description: Human Semenogelin I ELISA Kit |
Diabeton |
|||
413648 | MedKoo Biosciences | 5.0g | EUR 234 |
Human Semenogelin I (SEMG1) Protein |
|||
20-abx168081 | Abbexa |
|
|
Human Semenogelin I (SEMG1) Protein |
|||
abx168081-1ml | Abbexa | 1 ml | EUR 212.5 |
ELISA Kit for Semenogelin I (SEMG1) |
|||
SEH185Hu | Cloud-Clone | 96Т | EUR 700 |
Human Semenogelin I (SEMG1) CLIA Kit |
|||
20-abx495402 | Abbexa |
|
|
Human Semenogelin I (SEMG1) ELISA Kit |
|||
DLR-SEMG1-Hu | DL Develop | 96T | EUR 463 |
Description: serum, plasma, seminal plasma or other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
DLR-SEMG1-Hu-48T | DL Develop | 48T | EUR 620.4 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
DLR-SEMG1-Hu-96T | DL Develop | 96T | EUR 807.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids. |
Human SEMG1(Semenogelin I) ELISA Kit |
|||
ELK4641-48T | ELK Biotech | 48T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human SEMG1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human SEMG1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human SEMG1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human SEMG1 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human SEMG1(Semenogelin I) ELISA Kit |
|||
ELK4641-96T | ELK Biotech | 96T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human SEMG1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human SEMG1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human SEMG1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human SEMG1 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKU07271-48T | Biomatik Corporation | 48T | EUR 555.66 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKU07271-5x96T | Biomatik Corporation | 5x96T | EUR 3770.55 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKU07271-96T | Biomatik Corporation | 96T | EUR 793.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKN48382-48T | Biomatik Corporation | 48T | EUR 378.7 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKN48382-5x96T | Biomatik Corporation | 5x96T | EUR 2569.75 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EKN48382-96T | Biomatik Corporation | 96T | EUR 541 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
DL-SEMG1-Hu | DL Develop | 96T | EUR 441 |
Description: serum, plasma, seminal plasma or other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
EK16572 | SAB | 96Т | EUR 768 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
abx571776-96tests | Abbexa | 96 tests | EUR 904.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
abx250766-96tests | Abbexa | 96 tests | EUR 904.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
20-abx153055 | Abbexa |
|
|
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RD-SEMG1-Hu-48T | Reddot Biotech | 48T | EUR 452.7 |
Description: serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RD-SEMG1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 625.2 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RD-SEMG1-Hu-96T | Reddot Biotech | 96T | EUR 646.7 |
Description: serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RD-SEMG1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 867.6 |
Human Semenogelin I(SEMG1)ELISA Kit |
|||
QY-E01566 | Qayee Biotechnology | 96T | EUR 448.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RDR-SEMG1-Hu-48T | Reddot Biotech | 48T | EUR 475.34 |
Description: serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RDR-SEMG1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 652.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RDR-SEMG1-Hu-96T | Reddot Biotech | 96T | EUR 679.04 |
Description: serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
RDR-SEMG1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 907.2 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
SEH185Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5677.8 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
SEH185Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 572.76 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
SEH185Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 766.8 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
SEH185Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3090.6 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
4-SEH185Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
SL2440Hu | Sunlong | 96 Tests | EUR 468 |
Semenogelin I (SEMG1) Polyclonal Antibody |
|||
CAU22029-100ul | Biomatik Corporation | 100ul | EUR 235.2 |
Semenogelin I (SEMG1) Polyclonal Antibody |
|||
CAU22029-200ul | Biomatik Corporation | 200ul | EUR 294 |
SEMG1 (untagged)-Human semenogelin I (SEMG1) |
|||
SC303261 | Origene Technologies GmbH | 10 µg | Ask for price |
ELISA kit for Human SEMG1 (Semenogelin I) |
|||
ELK4641 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
Description: A sandwich ELISA kit for detection of Semenogelin I from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Polyclonal Antibody to Semenogelin I (SEMG1) |
|||
PAH185Hu01 | Cloud-Clone | 100ul | EUR 245 |
SEMG1 (GFP-tagged) - Human semenogelin I (SEMG1) |
|||
RG216046 | Origene Technologies GmbH | 10 µg | Ask for price |
Mixture of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Analysis
Background: Coronavirus illness 2019 (COVID-19), brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mostly recognized by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases just a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (roughly 80%). We evaluated the efficiency of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the mixture of RT-PCR and the IgG assay for COVID-19 analysis.
Strategies: On this retrospective research, 206 samples from 70 COVID-19 instances at two hospitals in Tokyo that had been constructive utilizing RT-PCR had been used to investigate the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Pink Cross Society (N=100) samples had been used to guage specificity.
Outcomes: Sensitivity elevated day by day after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case teams. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 instances with a number of samples and from one other case with a constructive consequence within the IgG assay for the primary accessible pattern.
Conclusions: The mix of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the constraints of every technique.
Simultaneous Molecular Detection of Frequent Bacterial Enteropathogens in Youngsters with Diarrhea by Multiplex-PCR Assay
Background: Diarrhea stays a serious risk to kids in low- and middle-income international locations, which is the second explanation for dying amongst kids on the planet. The intention of the current research was to develop and consider a multiplex-PCR assay for direct detection of widespread bacterial enteropathogens in fecal specimens.
Strategies: 100 and three stool specimens had been collected from kids beneath 5 years of age with gastroenteritis throughout a six-month interval in Ilam, Iran. The multiplex PCR assay concurrently detected Shigella spp., Campylobacter jejuni, Enteropathogenic Escherichia coli (EPEC), Enterotoxigenic Escherichia coli (ETEC), and Salmonella enterica in stool samples.
Outcomes: Our outcomes demonstrated that the prevalence of Shigella spp. Campylobacter jejuni, EPEC, ETEC, and Salmonella enterica had been 21.35%, 10.67%, 1.94%, 0.97% and 0%, respectively. As well as, Shigella spp. with Campylobacter jejuni and EPEC with Campylobacter jejuni coinfection had been noticed in pattern 11 (10.67%). The analytical sensitivity of the multiplex PCR assay was estimated to be 0.01 ng/µL of genomic DNA from tradition. The analytical specificity was decided to be 100% through the use of widespread and customary enteropathogenic bacterial strains.
Conclusions: The molecular technique developed within the research was speedy, delicate, and particular for detection of widespread bacterial enteropathogens.
Screening of ZIKA virus an infection amongst dengue-like sickness sufferers with damaging RT-PCR for dengue virus in Punjab – Pakistan
Goal: To detect ZIKV utilizing reverse transcription-polymerase chain response (RT-PCR) amongst medical samples examined damaging for Dengue virus (DENV) by RT-PCR in Punjab, 2016.
Strategies: A descriptive cross-sectional research was carried out for length of two months. Whole of 506 samples had been collected inside seven days from onset of sickness from throughout hospitals of Punjab, Pakistan of which 350 had been chosen merely randomly to check for presence of ZIKV through the use of “Trioplex Actual-Time RT-PCR Assay (Trioplex)”. Cohen’s kappa coefficient (κ) and 95% confidence interval (CI) had been used to evaluate the diploma of concordance between DENV constructive outcomes of non-structural protein 1 (NS1) and IgM solid-phase enzyme immunoassay (ELISA).
Outcomes: No samples had been constructive for any ZIKV, DENV or Chikungunya virus (CHIKV) by Trioplex. Among the many 350 samples, 26 samples had been constructive concordant and the diploma of concordance between NS1- and IgM-ELISA was 13% and κ coefficient was -0.71 (95% CI -0.79, -0.63).
Conclusion: At research time, no samples had been constructive for ZIKV. Strengthening laboratory capability to verify arboviruses for Punjab’s laboratories is warranted. Trioplex RT-PCR has 100% sensitivity so there are nominal probabilities of false damaging outcomes. Establishing syndromic surveillance for Zika and conducting a sero-surveillance survey for Zika in areas with excessive human and Aedes mosquito density are advisable in Punjab.
Repositive RT-PCR take a look at in discharged COVID-19 sufferers throughout medical isolation commentary
Targets: The epidemiological and medical traits of sufferers with coronavirus illness 2019 (COVID-19) have been researched. Nonetheless, the prevalence of repositivity by real-time PCR for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stays unclear.
Strategies: A retrospective research was carried out involving 599 discharged sufferers with COVID-19 in a single medical centre. The medical options of sufferers throughout their hospitalization and 14-day post-discharge quarantine had been collected.
Outcomes: A complete of 122 sufferers (20.4%) out of 599 sufferers retested constructive after discharge. Particularly, 94 (15.7%) retested constructive inside 24 h of discharge, and one other 28 sufferers (4.7%) had been repositive on day 7 after discharge, though none confirmed any medical symptomatic recurrence. Each repositives and non‑repositives have related patterns of IgG and IgM. Notably, the size of hospitalization of non-repositive sufferers was longer than that of 24-h repositive sufferers and 7-day repositive sufferers. As well as, the size of hospitalization of 24-h repositive sufferers was shorter than that of 7-day repositive sufferers, indicating that the size of hospitalization was additionally a determinant of viral shedding.
Conclusion: Our research supplies additional info for bettering the administration of recovered and discharged sufferers, and additional research must be carried out to elucidate the infectiveness of people with extended or RNA repositivity.